Oxford BioMedica PLC banner

Oxford BioMedica PLC
LSE:OXB

Watchlist Manager
Oxford BioMedica PLC Logo
Oxford BioMedica PLC
LSE:OXB
Watchlist
Price: 621 GBX -0.64% Market Closed
Market Cap: £750.6m

Wall Street
Price Targets

OXB Price Targets Summary
Oxford BioMedica PLC

Wall Street analysts forecast OXB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OXB is 892.06 GBX with a low forecast of 779.72 GBX and a high forecast of 1 228.5 GBX.

Lowest
Price Target
779.72 GBX
26% Upside
Average
Price Target
892.06 GBX
44% Upside
Highest
Price Target
1 228.5 GBX
98% Upside
Oxford BioMedica PLC Competitors:
Price Targets
WLFC
Willis Lease Finance Corp
-8% Downside
LAND
Gladstone Land Corp
19% Upside
DXPE
DXP Enterprises Inc
-5% Downside

Revenue
Forecast

25% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
25% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

For the last 14 years the compound annual growth rate for Oxford BioMedica PLC's revenue is 25%. The projected CAGR for the next 3 years is 30%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OXB's stock price target?
Price Target
892.06 GBX

According to Wall Street analysts, the average 1-year price target for OXB is 892.06 GBX with a low forecast of 779.72 GBX and a high forecast of 1 228.5 GBX.

What is Oxford BioMedica PLC's Revenue forecast?
Projected CAGR
30%

For the last 14 years the compound annual growth rate for Oxford BioMedica PLC's revenue is 25%. The projected CAGR for the next 3 years is 30%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett